CA1073455A - (aroyl-2'eth-1'yl)-1 (acetamido-4"piperazin-1"methyl)-2 benzimidazoles, leur application en therapeutique et leur procede de preparation_______ - Google Patents
(aroyl-2'eth-1'yl)-1 (acetamido-4"piperazin-1"methyl)-2 benzimidazoles, leur application en therapeutique et leur procede de preparation_______Info
- Publication number
- CA1073455A CA1073455A CA243,226A CA243226A CA1073455A CA 1073455 A CA1073455 A CA 1073455A CA 243226 A CA243226 A CA 243226A CA 1073455 A CA1073455 A CA 1073455A
- Authority
- CA
- Canada
- Prior art keywords
- group
- formula
- carbon atoms
- alpha
- alkyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/10—Radicals substituted by halogen atoms or nitro radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7500724A FR2297045A1 (fr) | 1975-01-10 | 1975-01-10 | Nouveaux (aroyl-2' eth-1' yl)-1 (acetamido-4'' piperazin-1'' yl methyl)-2 benzimidazoles a proprietes antisecretoire gastrique et antiulcereuse |
| FR7537297A FR2333510A2 (fr) | 1975-12-05 | 1975-12-05 | Nouveaux (aroyl-2' eth-1 yl)-1 (acetamido-4'' piperazin-1'' yl methyl)-2 benzimidazoles, leur application en therapeutique et leur procede de preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1073455A true CA1073455A (fr) | 1980-03-11 |
Family
ID=26218682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA243,226A Expired CA1073455A (fr) | 1975-01-10 | 1976-01-08 | (aroyl-2'eth-1'yl)-1 (acetamido-4"piperazin-1"methyl)-2 benzimidazoles, leur application en therapeutique et leur procede de preparation_______ |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS6020386B2 (enExample) |
| AU (1) | AU509084B2 (enExample) |
| CA (1) | CA1073455A (enExample) |
| CH (1) | CH612675A5 (enExample) |
| DE (1) | DE2557446C2 (enExample) |
| ES (1) | ES444064A1 (enExample) |
| GB (1) | GB1487128A (enExample) |
| IT (1) | IT1062803B (enExample) |
| LU (1) | LU74043A1 (enExample) |
| MX (1) | MX3428E (enExample) |
| NL (1) | NL7600224A (enExample) |
| SE (1) | SE421527B (enExample) |
| SU (1) | SU651701A3 (enExample) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2190439B1 (enExample) * | 1972-07-06 | 1975-06-20 | Delalande Sa |
-
1975
- 1975-12-16 GB GB51396/75A patent/GB1487128A/en not_active Expired
- 1975-12-18 LU LU74043A patent/LU74043A1/xx unknown
- 1975-12-19 DE DE2557446A patent/DE2557446C2/de not_active Expired
-
1976
- 1976-01-03 ES ES444064A patent/ES444064A1/es not_active Expired
- 1976-01-06 MX MX001645U patent/MX3428E/es unknown
- 1976-01-07 CH CH12876A patent/CH612675A5/xx not_active IP Right Cessation
- 1976-01-08 CA CA243,226A patent/CA1073455A/fr not_active Expired
- 1976-01-08 AU AU10117/76A patent/AU509084B2/en not_active Expired
- 1976-01-08 SE SE7600116A patent/SE421527B/xx unknown
- 1976-01-08 SU SU762305959A patent/SU651701A3/ru active
- 1976-01-08 JP JP761833A patent/JPS6020386B2/ja not_active Expired
- 1976-01-09 NL NL7600224A patent/NL7600224A/xx not_active Application Discontinuation
- 1976-01-09 IT IT67044/76A patent/IT1062803B/it active
Also Published As
| Publication number | Publication date |
|---|---|
| DE2557446C2 (de) | 1984-11-29 |
| IT1062803B (it) | 1985-02-11 |
| GB1487128A (en) | 1977-09-28 |
| SU651701A3 (ru) | 1979-03-05 |
| AU1011776A (en) | 1977-07-14 |
| AU509084B2 (en) | 1980-04-17 |
| CH612675A5 (en) | 1979-08-15 |
| JPS51131885A (en) | 1976-11-16 |
| NL7600224A (nl) | 1976-07-13 |
| LU74043A1 (enExample) | 1976-11-11 |
| ES444064A1 (es) | 1977-08-16 |
| SE421527B (sv) | 1982-01-04 |
| DE2557446A1 (de) | 1976-07-15 |
| JPS6020386B2 (ja) | 1985-05-21 |
| SE7600116L (sv) | 1976-07-12 |
| MX3428E (es) | 1980-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4207324A (en) | 1,2-Di-Substituted-4-haloimidazole-5-acetic acid derivatives and their use | |
| PL143010B1 (en) | Process for preparing novel derivatives of 1,2,3,5-tetrahydroimidazo/2,1-b/quinazoline | |
| FR2503155A2 (fr) | Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme | |
| EP0385850A2 (fr) | Nouveaux dérivés de benzimidazoles et azabenzimidazoles, leurs procédés de préparation, intermédiaires de synthèse, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et les ulcères duodénaux | |
| CH618975A5 (enExample) | ||
| FR2673182A1 (fr) | Piperazines n,n'-disubstituees, leur procede de preparation et leur application en therapeutique. | |
| LU83400A1 (fr) | Nouvelles n-aryl oxazolidinones-2,leur procede de preparation et leur application en therapeutique | |
| JPS63310872A (ja) | ドーパミン−β−ヒドロキシラーゼ抑制剤 | |
| JPH04282374A (ja) | 新規5h−ベンゾジアゼピン誘導体、それを含有してなる製剤組成物、およびそれらの製造方法 | |
| CA2059311A1 (fr) | Composes de structure aryltriazinique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| CH632268A5 (de) | Verfahren zur herstellung von neuen heterocyclylaminoderivaten. | |
| EP0008259A1 (fr) | Nouveaux dérivés de la pipéridylbenzimidazolinone, leurs procédés de préparation et les compositions pharmaceutiques les renfermant | |
| EP0209435B1 (fr) | Dérivés de l'hydroxy alkoxy 4-phénylpropyl indole, leurs sels, procédé et intermédiaires de préparation, application à titre de médicaments et compositions les renfermant | |
| CH497433A (fr) | Procédé de préparation de nouveaux dérivés des benzimidazoles | |
| EP0502110B1 (fr) | Derives d'(hetero) arylmethyloxy-4 phenyl diazole, leur procede de preparation et leur application en therapeutique | |
| CA2306428C (fr) | Derives de la 3-oxo-2(h)-1,2,4 - triazine en tant que ligands des recepteurs 5ht1a | |
| EP0275762B1 (fr) | Dérivés de l'indole carboxamide ainsi que leurs sels, procédé et intermédiaires de préparation, application à titre de médicaments de ces dérivés et compositions les renfermant | |
| CZ357190A3 (en) | Dihydropyrimidothiazine derivatives, process of their preparation and pharmaceutical compositions containing thereof | |
| EP0282390A1 (fr) | Nouveaux dérivés de l'acide (dihydro-2,3 oxo-2 benzofurannyl-3)-2 acétique et les compositions pharmaceutiques qui les contiennent | |
| LT4457B (lt) | Nauji pasižymintys antispazminiu aktyvumu imidazolin-2,4-dionai, turintys orto-pakeistą aril(alkil)-radikalą 1 padėtyje, ir jų gavimo būdas | |
| US5322846A (en) | 4-methylthiazole derivatives, their methods of preparation and the pharmaceutical compositions in which they are present | |
| EP0347305B1 (fr) | [(Aryl-4-pipérazinyl-1)-2 éthoxy]-3 p-cymène, les dérivés ortho, méta, para monosubstitués ou disubstitués sur le noyau phényle dudit produit, le procédé de préparation desdits dérivés, et les médicaments contenant lesdits composés comme principe actif | |
| EP0275221B1 (fr) | Nouveaux dérivés du N-(1H-indol 4-yl) benzamide ainsi que leurs sels, leur application à titre de médicaments et les compositions les renfermant | |
| BE819057A (fr) | Nouveaux derives arylamino pyrimidiniques | |
| EP0663903B1 (fr) | Derives de dihydro-1,2 oxo-2 amino-3 quinoxalines, leur preparation et leur application en therapeutique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |